NeuroPace (NPCE) Change in Account Payables (2020 - 2026)
NeuroPace (NPCE) posted quarterly Change in Account Payables of $2.2 million for Q1 2026, up 127.23% year-over-year from $966000.0 in Q1 2025, and up 192.03% quarter-over-quarter from -$2.4 million in Q4 2025.
NeuroPace (NPCE) Change in Account Payables (2020 - 2026) Analysis & Trends
NeuroPace's Change in Account Payables history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 127.23% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $499000.0 (down 27.37% YoY), while the FY2025 annual figure was -$730000.0, down 208.79% from the prior year.
- Change in Account Payables for Q1 2026 stood at $2.2 million, up from -$2.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $2.2 million in Q1 2026, with the low at -$2.4 million in Q4 2025.
- The 5-year median for Change in Account Payables is -$22000.0 (2023), against an average of $177823.5.
- Peak annual rise in Change in Account Payables reached 592.23% in 2024, while the deepest fall reached 4090.91% in 2024.
- NeuroPace's Change in Account Payables stood at $855000.0 in 2022, then advanced by 23.39% to $1.1 million in 2023, then fell by 26.73% to $773000.0 in 2024, then plunged by 408.54% to -$2.4 million in 2025, then jumped by 192.03% to $2.2 million in 2026.
- Business Quant data shows NPCE's Change in Account Payables at $2.2 million in Q1 2026, -$2.4 million in Q4 2025, and -$48000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | -212,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -212,000.00 |
| Jun 30, 2026 | -212,000.00 |
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Sep 30, 2025 | -48,000.00 |
| Sep 30, 2025 | -48,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Mar 31, 2024 | 950,000.00 |